Gene testing for diagnosing and treating heart disease
Utility of Gene Test Analysis for Diagnosis, Prognosis and Treatment of Patients With Genetic Arrhythmic Heart Disease: the ARRHYTHMIC GENE-HEART
This study is trying to see if gene testing can help doctors better diagnose and treat heart conditions related to arrhythmias in patients at the Cardiogenetic Center in Italy.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Sex | All |
| Sponsor | University Hospital of Ferrara Academic / other |
| Locations | 1 site (Ferrara) |
| Trial ID | NCT06898307 on ClinicalTrials.gov |
What this trial studies
This observational study aims to enroll patients at the Cardiogenetic Center of the University of Ferrara, Italy, to collect detailed clinical, genetic, and electrophysiological data from individuals with suspected or confirmed arrhythmogenic conditions. The registry will document patient demographics, family history, clinical presentations, diagnostic findings, and treatment outcomes to enhance understanding of the genetic basis of arrhythmias. By facilitating long-term follow-up, the study seeks to assess the natural history of these disorders and the effectiveness of various therapeutic interventions. Ultimately, it aims to identify risk factors associated with adverse outcomes, such as sudden cardiac death.
Who should consider this trial
Good fit: Ideal candidates are patients evaluated at the Cardiogenetic Center who have a proven cardiogenetic disease.
Not a fit: Patients who do not have a cardiogenic disease or refuse to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and personalized treatment strategies for patients with genetic arrhythmic heart disease.
How similar studies have performed: Other studies in cardiogenetics have shown success in improving diagnosis and management of inherited cardiovascular conditions, indicating that this approach is promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients evaluated at the Cardiogenetic Center of the University of Ferrara in Ferrara, Italy. * Having a proven cardiogenetic disease Exclusion Criteria: * Refuse to provide informed consents * Patients not having a cardiogenic disease
Where this trial is running
Ferrara
- Department of Cardiology, University Hospital of Ferrara — Ferrara, Italy (Recruiting)
Study contacts
- Principal investigator: Cristina Balla, MD PhD — Università degli Studi di Ferrara
- Study coordinator: Cristina Balla, MD PhD
- Email: bllcst@unife.it
- Phone: +39 0532 239886
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.